Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
BRISTOL-MYERS SQUIBB COMPANY	BMY	Buenos Aires S.E.	804	16,212 ARS	Stock
BRISTOL-MYERS SQUIBB COMPANY	BMY	Nyse +12 Other	13,328,687	44.01 USD	Stock
BRISTOL-MYERS SQUIBB COMPANY	BRM	Deutsche Boerse AG	1,253	40.82 EUR
BRISTOL-MYERS SQUIBB COMPANY	BRM	Frankfurt	5,369	40.62 EUR
BRISTOL-MYERS SQUIBB COMPANY	BMY *	Mexican S.E.	6,281	729 MXN
BRISTOL-MYERS SQUIBB COMPANY	BMY	Swiss Exchange	-	44.39 CHF
BRISTOL-MYERS SQUIBB COMPANY	BMY	Swiss Exchange	-	45.3 USD
BRISTOL-MYERS SQUIBB COMPANY	0R1F	London S.E.	-	44.14 USD
BRISTOL-MYERS SQUIBB COMPANY	BRM	Börse Stuttgart	736	40.7 EUR
BRISTOL-MYERS SQUIBB COMPANY	BMYS	Wiener Boerse	-	40.3 EUR
BRISTOL-MYERS SQUIBB COMPANY	BRM	BOERSE MUENCHEN	2,904	40.65 EUR
BRISTOL-MYERS SQUIBB COMPANY	BMY	Lima	91	44.1 USD
BRISTOL-MYERS SQUIBB COMPANY	4BMY	Borsa Italiana	18	40.66 EUR
BRISTOL-MYERS SQUIBB COMPANY	BMY	Berne S.E.	0	44.08 CHF
BRISTOL-MYERS SQUIBB COMPANY	BMYB34	Sao Paulo	675	225 BRL	Stock
MYERS INDUSTRIES, INC.	MYE	Nyse +2 Other	339,790	16.43 USD	Stock
MYERS INDUSTRIES, INC.	MJF	Deutsche Boerse AG	-	15 EUR
MYERS INDUSTRIES, INC.	MJF	BOERSE MUENCHEN	-	15.3 EUR
BRISTOL-MYERS SQUIBB COMPANY	CELG.RT	Nyse	2,828	0.0555 USD	Stock
BRISTOL-MYERS SQUIBB COMPANY	BMYMP	OTC Markets	6	790 USD	Stock
FAKTOR ZERTIFIKAT LONG - FACTOR 8X LONG BRISTOL MYERS INDEX	MF90S	Euronext Paris	-	- EUR	Certificat
FAKTOR ZERTIFIKAT LONG - FACTOR 5X LONG BRISTOL MYERS INDEX	KL34S	Euronext Paris	-	- EUR	Certificat
THE MEET KEVIN PRICING POWER ETF - USD	PP	Nyse	18,863	27.07 USD	ETF

News (965)

Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy	May. 14	BU
Transcript : Trinseo PLC, Q1 2024 Earnings Call, May 09, 2024	May. 09
Transcript : Select Medical Holdings Corporation, Q1 2024 Earnings Call, May 03, 2024	May. 03
Transcript : Accelerate Resources Limited - Special Call	Mar. 26
Transcript : Alnylam Pharmaceuticals, Inc. Presents at Canaccord Genuity ?Genetic Medicine for Generalists?, Mar-25-2024 01:00 PM	Mar. 25
Transcript : Myers Industries, Inc. - Analyst/Investor Day	Mar. 19
Vistra Corp. completed the acquisition of Energy Harbor Corp. from Avenue Capital Group, Nuveen Asset Management LLC and others.	Feb. 29	CI
Tapestry, Inc. Appoints Kevin Hourican and David Elkins to Board of Directors	Feb. 29	BU
Tapestry, Inc. Announces Board and Committee Appointments	Feb. 29	CI
Transcript : BWX Technologies, Inc. - Analyst/Investor Day	Feb. 28
Transcript : Select Medical Holdings Corporation, Q4 2023 Earnings Call, Feb 23, 2024	Feb. 23
Transcript : Marriott International, Inc., Q4 2023 Earnings Call, Feb 13, 2024	Feb. 13
The Planting Hope Company Inc. Announces Board Changes	Feb. 08	CI
CSL Seqirus Commends the National Advisory Committee on Immunization for Preferential Recommendation of Enhanced Influenza Vaccines for Adults 65 and Older	Dec. 21	AQ
Transcript : Phillips Edison & Company, Inc. - Special Call	Dec. 14
Quarterhill Announces the Launch of the E-ZPass® Interoperability Hub	Dec. 14	PR
Transcript : Centene Corporation - Analyst/Investor Day	Dec. 12
Transcript : Ambarella, Inc., Q3 2024 Earnings Call, Nov 30, 2023	Nov. 30
Transcript : PZ Cussons plc - Shareholder/Analyst Call	Nov. 23
Transcript : Accent Group Limited - Shareholder/Analyst Call	Nov. 16
Transcript : Evotec SE - Analyst/Investor Day	Nov. 15
Transcript : Goodman Group - Shareholder/Analyst Call	Nov. 13
Bristol Myers Squibb’s First Disclosures and New Data at ASH 2023 Highlight Company’s Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology	Nov. 02	BU
North American Morning Briefing : Nasdaq Futures Retreat as Meta Pulls Back Further	23-10-26	DJ
Transcript : Advanced Micro Devices, Inc. - Special Call	23-10-17
How To Defend A Lawsuit Filed By So. Cal. Equal Access Group For ADA And Unruh Civil Rights Act Violations	23-10-16	AQ
Electronic Transaction Consultants and Central Texas Regional Mobility Authority Launch New Toll Service	23-10-11	AQ
Transcript : Insurance Australia Group Limited - Shareholder/Analyst Call	23-10-10
Transcript : Ginkgo Bioworks Holdings, Inc. - Analyst/Investor Day	23-10-03
Out with the old	23-10-02
Chico's FAS, Inc. Enters into Definitive Agreement to Be Acquired by Sycamore Partners for $1 Billion	23-09-28	PR
Transcript : Intel Corporation Presents at Intel Innovation 2023, Sep-19-2023 through Sep-20-2023	23-09-19
Cutera, Inc. Appoints Taylor Harris as Chief Executive Officer; Follows Comprehensive Search Process; Brings Over 20 Years of Healthcare Industry Experience and Operational Expertise	23-07-28	AQ
Cutera, Inc. Appoints Taylor Harris as Chief Executive Officer	23-07-27	BU
Coldwell Banker Reveals Winners of Its Annual 30 Under 30 Class of 2023 Awards	23-07-24	PR
Transcript : Johnson & Johnson, Q2 2023 Earnings Call, Jul 20, 2023	23-07-20
Priceline Unveils Trip Intelligence, its Summer 2023 Product Release - A Game-Changing Suite of Tools and Enhancements for Smarter Travel Booking	23-06-29	AQ
OBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. Appointed as Chief Executive Officer	23-06-02	GL
Cutera, Inc. Announces Board Changes	23-05-19	CI
Southwest Gas : Regulation FD Presentation - Form 8-K	23-05-18	PU
Bristol Myers Squibb to Highlight Diversified Approaches and Commitment to Improving Outcomes for Patients with Cancer and Serious Blood Disorders at ASCO, EHA and ICML 2023	23-05-11	BU
Transcript : Iluka Resources Limited - Shareholder/Analyst Call	23-05-09
Cutera Announces Agreements with Pura Vida and RTW	23-05-09	BU
Transcript : Alerus Financial Corporation - Shareholder/Analyst Call	23-05-08
Transcript : Trinseo PLC, Q1 2023 Earnings Call, May 05, 2023	23-05-05

1234NextSee all

Companies (18)

MYER HOLDINGS LIMITED 375 M $

Myer Holdings Limited is an Australia-based company that is engaged in the department store business. The Company operates approximately 58 department stores across Australia, as well as its online business, myer.com.au. The Companyâs merchandise offer ...

INTERNATIONAL STAR, INC. 4 M $

International Star, Inc. operates, through its wholly owned subsidiary, Budding Equity Inc., a royalty-based business that owns intellectual property contracts with movie studios, which provide for the licensing of that intellectual property (IP) to third ...

EXELIXIS, INC. 6 091 M $

Exelixis, Inc. is an oncology company. The Company is engaged in developing medicines and combination regimens at the forefront of cancer care. It has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, ...

DEVMAR EQUITIES, INC. 25 964 $

DevMar Equities, Inc. is involved in real estate development. The Company is engaged in real estate acquisition, development, management, and operation in multifamily, mixed-use and hospitality markets. Its subsidiaries include DevMar Baum Boutique, LLC a ...

TAPINATOR, INC. 1 M $

Tapinator, Inc. develops and publishes games for mobile platforms. The Companyâs portfolio includes over 300 titles that have over 500 million mobile downloads, including games such as Video Poker Classic and Crypto Trillionaire. It publishes two types ...

EAST AFRICAN BREWERIES PLC 930 M $

East African Breweries Limited specializes in the production and marketing of beers and spirits. The group's activity is organized around 4 sectors: - brewing and sale of beers: Tusker, Bell Lager, Pilsner, Guinness, White Cap, Senator and Allsopps names ...

ONE LIBERTY PROPERTIES, INC. 516 M $

One Liberty Properties, Inc. is a self-administered and self-managed real estate investment trust. The Company acquires, owns and manages a geographically diversified portfolio consisting primarily of industrial and retail properties. The Company owns app ...

MYERS INDUSTRIES, INC. 611 M $

Myers Industries, Inc. is a manufacturer of a range of polymer products for industrial, agricultural, automotive, commercial and consumer markets. It is also a distributor of tools, equipment and supplies for the tire, wheel and under-vehicle service indu ...

INTENSITY THERAPEUTICS, INC. 67 M $

Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company. The Company is engaged in developing treatments that address both the regional and systemic nature of a patientâs cancer. Its platform creates patented anti-cancer product cand ...

2SEVENTY BIO, INC. 247 M $

2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). ...

12Next

Insiders

Kevin Myers is currently the Director & Chief Product & Marketing Officer at AiAdvertising, Inc. He previously held positions as Principal at Baxter Healthcare Corp., Sterling Commerce (America), Inc., IMR16, Inc,, Sage Software, Inc., American Hospital Supply Corp., and Frito-Lay North America, Inc. From 2018 to 2020, he served as the Chief Marketing & Information Officer at Donatos Pizzeria LLC.
He also worked as the Executive Vice President-Marketing at Cold Stone Creamery, Inc. and as the General Manager at Majority Strategies LLC from 2015 to 2018.
Mr. Myers obtained his undergraduate degree from The Ohio State University.

Kevin R. Myers

Kevin L. Myers

Kevin Myers

Currently, Kevin L. Myers holds the position of Senior Vice President-Research & Development at Hormel Foods Corp. Dr. Myers is also Member of The American Meat Science Association and Member of Institute of Food Technologists, Inc. He received an undergraduate degree, a doctorate and a graduate degree from Iowa State University.

No results for this search